PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-441 Cr | ₹-422 Cr | ₹818 Cr | ₹794 Cr | ₹3,977 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-441 Cr |
| Mar2024 | ₹-422 Cr |
| Mar2023 | ₹818 Cr |
| Mar2022 | ₹794 Cr |
| Mar2021 | ₹3,977 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-441 Cr | Negative | |
| Mar2024 | ₹-422 Cr | Negative | |
| Mar2023 | ₹818 Cr | 2.97 | |
| Mar2022 | ₹794 Cr | -80.03 | |
| Mar2021 | ₹3,977 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,632.7 Cr | -1.9% | 4.9% | -17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -1.9% |
4.9% |
-17.3% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses